How to use scorecard? Learn more
How to use scorecard? Learn more
Expense RatioExpense Ratio | No LabelNo Label | No LabelNo Label |
---|---|---|
0.91 | 52.81 | 2.10 |
No LabelNo Label | No LabelNo Label | No LabelNo Label |
---|---|---|
1.47 | 55.47 | 0.84 |
PlanPlan | Lock inLock in | Exit LoadExit Load |
---|---|---|
IDCW | 0 yrs | 1.00% |
SIP Inv.SIP Inv. | Min. LumpsumMin. Lumpsum |
---|---|
Allowed | ₹ 100 |
BenchmarkBenchmark |
---|
BSE Health Care - TRI |
Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
Returns
Scheme
Ratios
Mutual Fund | 1Y Returns1Y Returns | 3Y CAGR3Y CAGR | Life CAGRLife CAGR |
---|---|---|---|
HDFC Pharma and Healthcare Fund(IDCW) | 35.54% | — | 44.56% |
Nippon India Pharma Fund(IDCW) | 12.09% | 16.80% | 11.36% |
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout) | 22.66% | 15.29% | 15.90% |
SBI Healthcare Opp Fund(IDCW-Payout) | 29.65% | 24.98% | 16.88% |
Actual
Target
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Equity
Others
Holdings
13.22 %
Holdings
7.89 %
Holdings
7.18 %
HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).
No.of Schemes
83
Total AUM
₹ 7,63,261.50 Cr.
Nikhil Mathur
AUM: ₹1,577.12 Cr.
|
Exp: 7yrs
PGDM - IMT, B.E. (Civil), CFA (USA)
Over 7 years of experience in equity research and 2 years in financial advisory.
Manager Performance (0)
Investment frequency
Monthly
One Time
Monthly Investment Amt. (₹)
Investment period (years)
You make
Invested period < 1 year
Gains are treated as short-term capital gains and taxed at 20%
Invested period > 1 year
Gains are treated as long-term capital gains and taxed at 12.5%